Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Sep-24 5:47 PM View:  | Relmada Therapeutics, Inc. (RLMD) | 09-Sep-24 | Private Purchase | 13,000 | $2.56 | $33,280.00 | 100% 0 to 13.0K | |
| 14-Mar-24 4:45 PM View: | Paxmedica, Inc. (PXMD) | 12-Mar-24 | Payment of Exercise | 992 | $0.69 | $684.48 | (29%) 3.38K to 2.39K | |
| 31-Jan-24 5:17 PM View: | Paxmedica, Inc. (PXMD) | 29-Jan-24 | Payment of Exercise | 97 | $0.76 | $73.72 | (3%) 3.48K to 3.38K | |
| 04-Jan-24 5:14 PM View: | Entero Therapeutics, Inc. (ENTO) | 02-Jan-24 | Grant | 19,633 | -- | -- | 6458% 0.3K to 19.94K | |
| 04-Oct-23 5:18 PM View: | Paxmedica, Inc. (PXMD) | 02-Oct-23 | Payment of Exercise | 6,536 | $0.29 | $1,869.95 | (10%) 65.58K to 59.05K | |
| 18-Sep-23 5:44 PM View: | Entero Therapeutics, Inc. (ENTO) | 15-Sep-23 | Sale | 10 | $0.43 | $4.30 | (< 1%) 6.11K to 6.1K | |
| 05-Sep-23 8:08 PM View: | Entero Therapeutics, Inc. (ENTO) | 31-Aug-23 | Sale | 6,053 | $0.30 | $1,815.90 | (50%) 12.16K to 6.11K | |
| 14-Apr-23 7:10 PM View: | Paxmedica, Inc. (PXMD) | 13-Apr-23 | Grant | 14,000 | -- | -- | 27% 51.58K to 65.58K | |
| 05-Jan-23 8:55 AM View: | Entero Therapeutics, Inc. (ENTO) | 03-Jan-23 | Grant | 84,745 | -- | -- | 21785% 0.39K to 85.13K | |
| 04-Oct-22 5:26 PM View: | Paxmedica, Inc. (PXMD) | 01-Oct-22 | Grant | 51,583 | -- | -- | 100% 0 to 51.58K | |
| 05-Apr-22 5:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Apr-22 | Option Exercise | 19,800 | $3.24 | $64,152.00 | 100% 0 to 19.8K | |
| 05-Apr-22 5:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Apr-22 | Planned Option Sale | 19,800 | $29.00 | $574,200.00 | (100%) 19.8K to 0 | |
| 02-Feb-23 10:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 03-Dec-21 | Gift | 10,000 | -- | -- | 100% 10.0K to 20.0K | |
| 02-Feb-23 10:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 03-Dec-21 | Gift | 10,000 | -- | -- | (50%) 20.0K to 10.0K | |
| 24-Sep-21 10:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 22-Sep-21 | Option Exercise | 10,000 | $4.60 | $46,000.00 | 152% 6.6K to 16.6K | |
| 24-Sep-21 10:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 22-Sep-21 | Market Option Sale (Planned) | 6,600 | $29.00 | $191,400.00 | (40%) 16.6K to 10.0K | |
| 19-Aug-21 5:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 17-Aug-21 | Option Exercise | 10,000 | $4.60 | $46,000.00 | 213% 4.7K to 14.7K | |
| 16-Jul-21 10:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 15-Jul-21 | Market Sale (Planned) | 3,300 | $31.54 | $104,088.00 | (41%) 8.0K to 4.7K | (< 1%) |
| 02-Jun-21 5:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Jun-21 | Market Sale (Planned) | 3,000 | $33.34 | $100,020.00 | (30%) 9.95K to 6.95K | 3% |
| 05-May-21 5:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 03-May-21 | Market Sale (Planned) | 3,000 | $38.22 | $114,647.00 | (23%) 12.95K to 9.95K | < 1% |
| 05-Apr-21 4:08 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Apr-21 | Market Sale (Planned) | 3,000 | $35.43 | $106,281.00 | (19%) 15.95K to 12.95K | (3%) |
| 02-Mar-21 4:08 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Mar-21 | Market Sale (Planned) | 3,000 | $33.87 | $101,618.00 | (16%) 18.95K to 15.95K | < 1% |
| 02-Feb-21 5:05 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Feb-21 | Market Sale (Planned) | 3,000 | $33.63 | $100,898.00 | (14%) 21.95K to 18.95K | (4%) |
| 05-Jan-21 4:00 PM View: | Relmada Therapeutics, Inc. (RLMD) | 04-Jan-21 | Market Sale | 3,000 | $32.11 | $96,341.70 | (12%) 24.95K to 21.95K | (3%) |
| 02-Dec-20 4:01 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Dec-20 | Market Sale | 3,000 | $35.74 | $107,219.00 | (11%) 27.95K to 24.95K | 10% |
| 02-Dec-20 4:01 PM View: | Relmada Therapeutics, Inc. (RLMD) | 24-Nov-20 | Gift | 21,223 | -- | -- | (43%) 49.17K to 27.95K | |
| 03-Nov-20 4:03 PM View: | Relmada Therapeutics, Inc. (RLMD) | 02-Nov-20 | Market Sale | 3,000 | $30.29 | $90,863.70 | (6%) 52.17K to 49.17K | (6%) |
| 02-Oct-20 4:02 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Oct-20 | Market Sale | 3,000 | $37.99 | $113,956.00 | (5%) 55.17K to 52.17K | 15% |
| 02-Sep-20 4:36 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Sep-20 | Market Sale | 3,000 | $34.74 | $104,207.00 | (4%) 79.66K to 76.66K | 8% |
| 19-Aug-20 4:13 PM View: | Relmada Therapeutics, Inc. (RLMD) | 18-Aug-20 | Payment of Exercise | 2,189 | $39.03 | $85,436.70 | (3%) 81.85K to 79.66K | 18% |
| 19-Aug-20 4:13 PM View: | Relmada Therapeutics, Inc. (RLMD) | 18-Aug-20 | Option Exercise | 26,362 | $3.24 | $85,412.90 | 48% 55.48K to 81.85K | (1%) |
| 04-Aug-20 3:30 PM View: | Relmada Therapeutics, Inc. (RLMD) | 03-Aug-20 | Market Sale | 3,000 | $35.74 | $107,213.00 | (5%) 58.48K to 55.48K | 10% |
| 02-Jul-20 1:26 PM View: | Relmada Therapeutics, Inc. (RLMD) | 01-Jul-20 | Market Sale | 3,000 | $43.89 | $131,677.00 | (5%) 61.48K to 58.48K | 27% |
| 23-Mar-20 8:15 PM View: | Entero Therapeutics, Inc. (ENTO) | 19-Mar-20 | Gift | 9,000 | -- | -- | 4% 225.0K to 234.0K | |
| 23-Mar-20 8:15 PM View: | Entero Therapeutics, Inc. (ENTO) | 19-Mar-20 | Gift | 9,000 | -- | -- | (4%) 234.0K to 225.0K | |
| 16-Feb-21 10:00 PM View: | Eton Pharmaceuticals, Inc. (ETON) | 19-Mar-20 | Gift | 3,500 | -- | -- | (5%) 71.92K to 68.42K | |
| 18-Mar-20 4:30 PM View: | Relmada Therapeutics, Inc. (RLMD) | 17-Mar-20 | Gift | 21,484 | -- | -- | 35% 61.48K to 82.97K | |
| 18-Mar-20 4:30 PM View: | Relmada Therapeutics, Inc. (RLMD) | 17-Mar-20 | Gift | 21,484 | -- | -- | (26%) 82.97K to 61.48K | |
| 13-Mar-20 4:10 PM View: | Entero Therapeutics, Inc. (ENTO) | 11-Mar-20 | Grant | 22,998 | $0.76 | $17,501.00 | 24% 94.0K to 117.0K | (48%) |
| 03-Jan-20 4:11 PM View: | Entero Therapeutics, Inc. (ENTO) | 31-Dec-19 | Grant | 7,500 | $1.04 | $7,800.00 | 9% 86.5K to 94.0K | (63%) |
| 27-Dec-19 5:10 PM View: | Relmada Therapeutics, Inc. (RLMD) | 24-Dec-19 | Payment of Exercise | 6,094 | $40.64 | $247,660.00 | (9%) 67.58K to 61.48K | 21% |
| 27-Dec-19 5:10 PM View: | Relmada Therapeutics, Inc. (RLMD) | 24-Dec-19 | Option Exercise | 67,578 | $3.66 | $247,641.00 | 100% 0 to 67.58K | (13%) |
| 01-Oct-19 2:27 PM View: | Entero Therapeutics, Inc. (ENTO) | 30-Sep-19 | Grant | 7,500 | $0.60 | $4,500.00 | 9% 79.0K to 86.5K | (38%) |
| 12-Aug-19 4:17 PM View: | Eton Pharmaceuticals, Inc. (ETON) | 09-Aug-19 | Market Purchase | 3,500 | $6.11 | $21,369.90 | 5% 68.42K to 71.92K | 42% |
| 02-Jul-19 6:41 PM View: | Entero Therapeutics, Inc. (ENTO) | 30-Jun-19 | Grant | 7,500 | $1.70 | $12,750.00 | 10% 71.5K to 79.0K | (78%) |
| 17-Jun-19 9:50 PM View: | Entero Therapeutics, Inc. (ENTO) | 13-Jun-19 | Grant | 30,000 | -- | -- | 42% 71.5K to 101.5K | |
| 29-Apr-19 8:24 PM View: | Entero Therapeutics, Inc. (ENTO) | 31-Mar-19 | Grant | 7,500 | $2.42 | $18,150.00 | 12% 64.0K to 71.5K | (85%) |
| 02-Jan-19 5:58 PM View: | Entero Therapeutics, Inc. (ENTO) | 28-Dec-18 | Grant | 7,500 | $1.29 | $9,675.00 | 16% 47.5K to 55.0K | (71%) |
| 02-Jan-19 5:58 PM View: | Entero Therapeutics, Inc. (ENTO) | 28-Dec-18 | Market Purchase | 9,000 | $1.41 | $12,690.00 | 16% 55.0K to 64.0K | (74%) |
| 15-Nov-18 7:24 PM View: | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-18 | Conversion | 8,675 | -- | -- | 16% 54.74K to 63.42K |